학술논문

Use of thiazolidinediones and glucagon-like peptide-1 receptor agonists and the risk of non-alcoholic fatty liver disease
Document Type
Journal
Source
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY; OCT 2020, 29 p128-p128, 1p. Supplement: 3
Subject
Language
English
ISSN
10991557